Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients

Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients

Autor Costa-Carvalho, Beatriz Tavares Autor UNIFESP Google Scholar
Martinez, Rose Mare Alvarez Autor UNIFESP Google Scholar
Dias, Aparecida Tiemi Nagao Google Scholar
Kubo, Christiana Arslanian Google Scholar
Barros-Nunes, Patricia Autor UNIFESP Google Scholar
Leiva, Lily Google Scholar
Solé, Dirceu Autor UNIFESP Google Scholar
Carneiro-Sampaio, Magda Maria Sales Google Scholar
Naspitz, Charles Kirov Autor UNIFESP Google Scholar
Sorensen, Ricardo Uhr Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Universidade Federal do Ceará Departamento de Toxicologia e Análises Clínicas
Universidade de São Paulo (USP)
Louisiana State University Health Science Center Department of Pediatrics
Resumo The majority of children with Down syndrome (DS) tend to have frequent bacterial infections including recurrent respiratory infections. Our objective was to evaluate the production of antibodies to pneumococcal polysaccharide antigens after active immunization in DS subjects. IgG antibodies to pneumococcal serotypes (1, 3, 6B, 9V, and 14) were measured before and 6 weeks after immunization with a 23-valent pneumococcal vaccine (Pneumo23®, Pasteur-Merrieux) in 6- to 13-year-old DS children (N = 17) and in aged-matched normal controls (N = 30). An adequate response was defined as a 4-fold increase over baseline or a post-immunization level of specific pneumococcal serotype antibody> or = 1.3 µg/mL. After immunization, all DS children had an increase in post-immunization levels against all serotypes analyzed. A 4-fold or more increase was observed in all DS children concerning serotypes 1 and 14, in 90% of subjects for serotypes 3 and 9V, and in 65% for serotype 6B. Regarding this increase, 8 of the 17 DS children had an adequate response to all serotypes analyzed, 8/17 patients to 4 serotypes and 1/17 to 3 serotypes. However, when we compared post-immunization levels between DS children and controls, we observed lower levels in the former group (P < 0.05) for all serotypes except serotype 3. We conclude that pneumococcal polysaccharide immunization could be beneficial for these DS children.
Assunto Down syndrome
Immunoglobulin
IgG subclass
Polysaccharide vaccine
Streptococcus pneumoniae
Pneumococcal antibodies
Idioma Inglês
Data 2006-12-01
Publicado em Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 39, n. 12, p. 1587-1592, 2006.
ISSN 0100-879X (Sherpa/Romeo, fator de impacto)
Editor Associação Brasileira de Divulgação Científica
Extensão 1587-1592
Fonte http://dx.doi.org/10.1590/S0100-879X2006005000047
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000243103300010
SciELO S0100-879X2006001200010 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/3357

Mostrar registro completo




Arquivos deste item

Nome: S0100-879X2006001200010.pdf
Tamanho: 528.7Kb
Formato: PDF
Descrição:
Visualizar/Abrir

Este item aparece na(s) seguinte(s) coleção(s)